This report contains market size and forecasts of Super Generic Drugs in global, including the following market information:
Global Super Generic Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Super Generic Drugs Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Super Generic Drugs companies in 2021 (%)
The global Super Generic Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Traditional Generic Drugs Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Super Generic Drugs include Teva, Novartis - Sandoz, Mylan, Sun Pharmaceutical, Aspen, Fresenius Kabi, Pfizer (Hospira), Sanofi and Aurobindo, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Super Generic Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Super Generic Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Super Generic Drugs Market Segment Percentages, by Type, 2021 (%)
Traditional Generic Drugs
Biosimilars
Global Super Generic Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Super Generic Drugs Market Segment Percentages, by Application, 2021 (%)
CNS
Cardiovascular
Genitourinary/Hormonal Drugs
Respiratory
Rheumatology
Diabetes
Oncology
Others
Global Super Generic Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Super Generic Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Super Generic Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Super Generic Drugs revenues share in global market, 2021 (%)
Key companies Super Generic Drugs sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Super Generic Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Teva
Novartis - Sandoz
Mylan
Sun Pharmaceutical
Aspen
Fresenius Kabi
Pfizer (Hospira)
Sanofi
Aurobindo
Lupin
Dr. Reddy's
Apotex
Cipla
ENDO (Par Pharmaceutical)
Stada Arzneimittel
Krka Group
Nichi-Iko Pharmaceutical
Valeant
Zydus Cadila
Hikma